InChI=1S/C20H30O4/c1- 2- 3- 4- 5- 10- 13- 16- 19(24- 23) 17- 14- 11- 8- 6- 7- 9- 12- 15- 18- 20(21) 22/h3- 4,7- 11,13- 14,17,19,23H,2,5- 6,12,15- 16,18H2,1H3,(H,21,22) /b4- 3- ,9- 7- ,11- 8- ,13- 10- ,17- 14+/t19- /m0/s1 |
HDMYXONNVAOHFR-UOLHMMFFSA-N |
C(=C\C/C=C\C=C\[C@H](C/C=C\C/C=C\CC)OO)\CCCC(O)=O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
|
|
platelet aggregation inhibitor
A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
(via 12-HPEPE )
|
|
View more via ChEBI Ontology
(5Z,8Z,10E,12S,14Z- 17Z)- 12- hydroperoxyicosa- 5,8,10,14,17- pentaenoic acid
|
(12S)- hydroperoxy- (5Z,8Z,10E,14Z- 17Z)- eicosapentaenoic acid
|
ChEBI
|
(12S)-hydroperoxy-(5Z,8Z,10E,14Z-17Z)-icosapentaenoic acid
|
ChEBI
|
(5Z,8Z,10E,12S,14Z-17Z)-12-hydroperoxyicosapentaenoic acid
|
ChEBI
|
12S-HpEPE
|
ChEBI
|
12S-hydroperoxy-5Z,8Z,10E,14Z,17Z-eicosapentaenoic acid
|
LIPID MAPS
|
22984144
|
PubMed citation
|
Europe PMC
|
3012585
|
PubMed citation
|
Europe PMC
|
|